Laddar...
A case of myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) successfully treated with lenalidomide
Lenalidomide is an immunomodulatory drug which is used to treat patients with MDS with deletion 5q chromosomal abnormality. In 2008, WHO introduced a new disease entity called MDS/MPN. No specific treatment for MDS/MPN subtype has yet been identified. We report a patient with MDS/MPN who responded w...
Sparad:
| I publikationen: | Clin Case Rep |
|---|---|
| Huvudupphovsman: | |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
John Wiley & Sons, Ltd
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4527794/ https://ncbi.nlm.nih.gov/pubmed/26273440 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.293 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|